Search clinical trials for: 2 - Insulin glargine QAM
Total 742 results
-
Eli Lilly and CompanyCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Russian Federation, United States, United Kingdom
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2China
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
SanofiCompleted
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Belgium, Hong Kong, United States, Germany, Portugal, Russian Federation, France, Canada, Finland, Austria, New Zealand, Spain, Poland, Thailand, Italy, Serbia, Korea, Republic of, Hungary, Mexico, Greece, Puerto Rico, Gu... and more
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
Emory UniversityCompletedHyperglycemiaUnited States
-
Emory UniversityMerck Sharp & Dohme LLCCompletedHyperglycemia | Type 2 Diabetes Mellitus | HospitalizationUnited States
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusIndia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
Sansum Diabetes Research InstituteNovo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States
-
HealthPartners InstituteTerminated
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
SanofiCompleted
-
Fundación Pública Andaluza para la Investigación...CompletedType 1 Diabetes MellitusSpain
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
Emory UniversityNovo Nordisk A/SCompleted
-
Tunitas Therapeutics, Inc.Tunitas Therapeutics Australia Pty LtdTerminatedAllergy and ImmunologyAustralia
-
University of Alabama at BirminghamRecruitingDiabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, GestationalUnited States
-
Nanjing First Hospital, Nanjing Medical UniversityUnknown
-
University of the Highlands and IslandsCompletedEndothelial DysfunctionUnited Kingdom
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
SanofiCompletedDiabetes Mellitus, Type 2Japan, Russian Federation, China, India, Pakistan, Philippines
-
The Coca-Cola CompanyCompletedObesity | OverweightSpain
-
Northwestern UniversityTerminatedInsulin Resistance, Diabetes | Hyperglycemia Steroid-inducedUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
Eli Lilly and CompanyCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
SanofiCompletedDiabetes Mellitus, Type 2France, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, Finland, Italy, Austria
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 DiabetesUnited States
-
Hospital Central "Dr. Ignacio Morones Prieto"CompletedAngiogenesis | Varicose Ulcer | Insulin | Wound Healing | Chronic Venous DiseaseMexico
-
Eli Lilly and CompanyCompletedDiabetes MellitusSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
SanofiCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, Germany, Korea, Republic of, Hungary, Spain, Puerto Rico, Poland, Mexico, Argentina, Czechia
-
NewLink Genetics CorporationCompleted
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
University of GuadalajaraCompletedType 2 Diabetes MellitusMexico
-
Chungbuk National University HospitalActive, not recruitingType 2 Diabetes Mellitus | Glucose, High BloodKorea, Republic of